SCHEMBL9528326

SCHEMBL9528326

CCC(C)c1nc(C(C)(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 8/20 0.35
AGTR2 P50052 8/20 0.35
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532014 0.91 AGTR1 (0.35) AGTR1AGTR2PPARG
SCHEMBL6006152 0.90 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL6005893 0.90 AGTR1 (0.34) AGTR1AGTR2PPARG
SCHEMBL8109241 0.87 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL6005842 0.87 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9529105 0.87 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL6006171 0.86 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL6006128 0.86 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL8105583 0.85 AGTR1 (0.37) AGTR1AGTR2PPARG
SCHEMBL9531030 0.85 AGTR1 (0.42) AGTR1AGTR2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed